Keele Research Repository

Article

Damgov, I, Bartosova, M, Marinovic, I, Istanbuly, O, Kieser, M, Lambie, MR ORCID: https://orcid.org/0000-0002-6285-5368, Davies, SJ ORCID: https://orcid.org/0000-0001-5127-4755, Schmitt, CP, Vychytil, A, Raby, A-C, Colmont, C, Aufricht, C, Johnson, DW, Fraser, D, Eringa, E, Morelle, J, Valdivielso, JM, Kratochwill, K, Jakulj, L, Vervloet, M, Ruiz-Ortega, M, Devuyst, O, Rossignol, P, Rutherford, P, Herzog, R and Meran, S (2023) IMPROVE-PD Finder: A Web-Based Platform to Search and Share Peritoneal Dialysis Biobank, Registry, and Clinical Trial Metadata. Kidney International Reports.

Ferreira, JP, Collier, T, Clark, AL, Mamas, MA ORCID: https://orcid.org/0000-0001-9241-8890, Rocca, H-PB-L, Heymans, S, González, A, Ahmed, FZ, Petutschnigg, J, Mujaj, B, Cuthbert, J, Rouet, P, Pellicori, P, Mariottoni, B, Cosmi, F, Edelmann, F, Thijs, L, Staessen, JA, Hazebroek, M, Verdonschot, J, Rossignol, P, Girerd, N, Cleland, JG and Zannad, F (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal - Cardiovascular Pharmacotherapy, 8 (2). 149 - 156.

Ferreira, JP, Verdonschot, J, Wang, P, Pizard, A, Collier, T, Ahmed, FZ, Brunner-La-Rocca, H-P, Clark, AL, Cosmi, F, Cuthbert, J, Díez, J, Edelmann, F, Girerd, N, González, A, Grojean, S, Hazebroek, M, Khan, J, Latini, R, Mamas, MA ORCID: https://orcid.org/0000-0001-9241-8890, Mariottoni, B, Mujaj, B, Pellicori, P, Petutschnigg, J, Pieske, B, Rossignol, P, Rouet, P, Staessen, JA, Cleland, JGF, Heymans, S, Zannad, F and Consortium, HOMAGE (Heart Omics in AGEing) (2021) Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF. JACC: Heart Failure, 9 (4). 268 - 277.

Cleland, JGF, Ferreira, JP, Mariottoni, B, Pellicori, P, Cuthbert, J, Verdonschot, JAJ, Petutschnigg, J, Ahmed, F, Cosmi, F, Brunner La Rocca, H-P, Mamas, MA ORCID: https://orcid.org/0000-0001-9241-8890, Clark, AL, Edelmann, F, Pieske, B, Khan, J, McDonald, K, Rouet, P, Stassen, J, Mujaj, B, González, A, Diez, J, Hazebroek, M, Heymanns, S, Latini, R, Grojean, S, Pizard, A, Girerd, N, Rossignol, P, Collier, TJ, Zannad, F and Committees & Investigators, HOMAGE Trial (2021) The Effect of Spironolactone on Cardiovascular Function and Markers of Fibrosis in People at Increased Risk of Developing Heart Failure: The Heart “OMics” in AGEing (HOMAGE) Randomised Clinical Trial. European Heart Journal, 42 (6). pp. 684-696.